PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
96.69%
Cash & equivalents yoy growth above 20% – a robust liquidity build. Warren Buffett would verify that this cash is effectively redeployed. Cross-check Return on Capital and Free Cash Flow.
No Data
No Data available this quarter, please select a different quarter.
96.69%
Cash + STI yoy growth above 20% – strong overall liquidity. Warren Buffett would check if this war chest is awaiting acquisitions or strategic moves.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
119.86%
Other current assets up over 5% yoy – potential ballooning of intangible or prepayments. Philip Fisher would scrutinize the nature of these assets carefully.
94.31%
Total current assets yoy growth ≥ 20% – robust short-term liquidity expansion. Warren Buffett would confirm if composition (cash vs. receivables) is healthy.
-6.34%
Declining PP&E may indicate underinvestment or asset sales. Seth Klarman would question future capacity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-4.92%
Declining non-current assets may signal asset sales or underinvestment. Howard Marks would investigate future growth implications.
No Data
No Data available this quarter, please select a different quarter.
78.33%
Total assets up ≥ 20% yoy – large expansion. Benjamin Graham checks if acquisitions or reinvestments are wisely priced.
-11.61%
Declining payables indicates faster supplier payments but reduces free financing. Howard Marks would verify liquidity remains adequate.
-42.55%
Declining short-term debt reduces immediate leverage risk. Benjamin Graham would see this as improving financial safety.
No Data
No Data available this quarter, please select a different quarter.
11.61%
Growth 10-20% – healthy pipeline. Benjamin Graham checks that delivery costs won't erode margins.
No Data
No Data available this quarter, please select a different quarter.
-11.56%
Declining current liabilities reduces short-term financial pressure. Seth Klarman would see this as improving liquidity position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-9.36%
Declining total non-current liabilities reduces long-term leverage risk. Benjamin Graham would see this as strengthening the balance sheet.
No Data
No Data available this quarter, please select a different quarter.
-11.23%
Declining total liabilities strengthens the balance sheet. Howard Marks would see this as reducing financial risk.
36.01%
Above 5% yoy – more significant share issuance. Philip Fisher demands a strong ROI or else it's dilution.
-2.61%
Declining retained earnings signals net losses or large dividends. Seth Klarman would investigate the sustainability of dividend policy.
-6.95%
Declining AOCI may indicate reduced unrealized gains or currency losses. Howard Marks would see this as potentially reducing volatility.
No Data
No Data available this quarter, please select a different quarter.
193.87%
Equity growth ≥ 10% yoy – a strengthening net worth. Warren Buffett checks if the ROE is healthy.
78.33%
≥ 12% yoy – significant balance sheet expansion. Benjamin Graham checks if the new capital is productive.
No Data
No Data available this quarter, please select a different quarter.
-9.95%
Declining total debt reduces leverage risk. Seth Klarman would see this as improving financial stability and flexibility.
-116.79%
Declining net debt indicates improving liquidity or deleveraging. Howard Marks would see this as strengthening financial position.